18.60
Finanzdaten der Nuvectis Pharma Inc-Aktie (NVCT)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Research and Development |
14.08%
4.684
|
4.106 | 5.086 | 5.774 | 3.613 |
| Operating Income/Loss |
14.97%
-7.197
|
-6.26 | -7.617 | -7.794 | -6.595 |
|
|
16.03%
-7.02
|
-6.05 | -7.314 | -7.462 | -6.334 |
| Basic Average Shares |
0.26%
23.48
|
23.41 | 0.4615 | 22.72 | 21.37 |
| Diluted Average Shares |
0.26%
23.48
|
23.41 | 0.4615 | 22.72 | 21.37 |
| Basic Earnings Per Share |
15.38%
-0.30
|
-0.26 | -0.31 | -0.44 | -0.30 |
| Diluted Earnings Per Share |
15.38%
-0.30
|
-0.26 | -0.31 | -0.44 | -0.30 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):